PMV Pharmaceuticals, Inc. Quarterly Marketable Securities, Current in USD from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
PMV Pharmaceuticals, Inc. quarterly Marketable Securities, Current history and growth rate from Q1 2021 to Q2 2024.
  • PMV Pharmaceuticals, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $164M, a 38.3% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $164M +$45.5M +38.3% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $150M +$63.8M +73.8% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $165M +$32.6M +24.6% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $150M -$9.15M -5.75% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $119M -$71.5M -37.5% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $86.5M -$80.7M -48.3% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $133M +$8.06M +6.47% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $159M +$28M +21.4% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $190M +$61.4M +47.6% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $167M +$44.5M +36.3% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $125M Dec 31, 2021 10-K 2023-03-01
Q3 2021 $131M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $129M Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $123M Mar 31, 2021 10-Q 2021-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.